A small percentage of AD cases are caused by genetic mutations in APP and presenilins identified in familial AD (FAD), where these mutations alter APP processing in favor of Aβ42 to drive the peptide aggregation thought to initiate disease. This evidence concerns the gene APP and Alzheimer disease.